High-affinity accumulation of chloroquine by mouse erythrocytes infected with Plasmodium berghei.
Washed erythrocytes infected with chloroquine-susceptible (CS) or with chloroquine-resistant (CR) P. berghei were used in model systems in vitro to study the accumulation of chloroquine with high affinity. The CS model could achieve distribution ratios (chloroquine in cells: chloroquine in medium) of 100 in the absence of substrate. 200-300 in the presence of 10 mM pyruvate or lactate, and over 600 in the presence of 1 mM glucose or glycerol. In comparable studies of the CR model, the distribution ratios were 100 in the absence of substrate and 300 or less in the presence of glucose or glycerol. The presence of lactate stimulated chloroquine accumulation in the CR model, whereas the presence of pyruvate did not. Lactate production from glucose and glycerol was undiminished in the CR model, and ATP concentrations were higher than in the CS model. Cold, iodoacetate, 2,4-dinitrophenol, or decreasing pH inhibited chloroquine accumulation in both models. These findings demonstrate substrate involvement in the accumulation of chloroquine with high affinity.In studies of the CS model, certain compounds competitively inhibited chloroquine accumulation, while others did not. This finding is attributable to a specific receptor that imposes structural constraints on the process of accumulation. For chloroquine analogues, the position and length of the side chain, the terminal nitrogen atom of the side chain, and the nitrogen atom in the quinoline ring are important determinants of binding to this receptor.
D000085:Acetates / Q000378:metabolism; D000409:Alanine / Q000378:metabolism; D000818:Animals; D001667:Binding, Competitive; D002738:Chloroquine / Q000097:blood* / Q000494:pharmacology; D004352:Drug Resistance, Microbial; D004912:Erythrocytes / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism; D005990:Glycerol / Q000378:metabolism; D006863:Hydrogen-Ion Concentration; D007288:Inosine / Q000378:metabolism; D007773:Lactates / Q000378:metabolism; D008288:Malaria / Q000378:metabolism*; D008297:Male; D051379:Mice; D010962:Plasmodium berghei / Q000187:drug effects*; D011773:Pyruvates / Q000378:metabolism; D013386:Succinates / Q000378:metabolism; D013696:Temperature
D000085:Acetates; D007773:Lactates; D011773:Pyruvates; D013386:Succinates; D007288:Inosine; D002738:Chloroquine; D005947:Glucose; D000409:Alanine; D005990:Glycerol